Published in Bipolar Disord on June 19, 2012
The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Front Psychiatry (2014) 1.14
The neural and genetic basis of executive function: attention, cognitive flexibility, and response inhibition. Pharmacol Biochem Behav (2013) 1.11
The impact of cafeteria diet feeding on physiology and anxiety-related behaviour in male and female Sprague-Dawley rats of different ages. Pharmacol Biochem Behav (2013) 0.78
The effects of reduced dopamine transporter function and chronic lithium on motivation, probabilistic learning, and neurochemistry in mice: Modeling bipolar mania. Neuropharmacology (2016) 0.76
An examination of the language construct in NIMH's research domain criteria: Time for reconceptualization! Am J Med Genet B Neuropsychiatr Genet (2016) 0.76
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry (2010) 4.85
Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry (2010) 2.98
The neurobiology of the switch process in bipolar disorder: a review. J Clin Psychiatry (2010) 1.94
Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine. Neuropsychopharmacology (2010) 1.65
Glutamatergic modulators: the future of treating mood disorders? Harv Rev Psychiatry (2010) 1.42
Dynamic regulation of mitochondrial function by glucocorticoids. Proc Natl Acad Sci U S A (2009) 1.38
A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol (2009) 1.28
Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology (2010) 1.25
The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior. J Neurosci (2008) 1.19
Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study. Biol Psychiatry (2005) 1.17
A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors. Proc Natl Acad Sci U S A (2010) 1.11
Does lithium prevent Alzheimer's disease? Drugs Aging (2012) 1.10
Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression. Prog Neuropsychopharmacol Biol Psychiatry (2011) 1.09
Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania. Neuropharmacology (2008) 1.07
Effects of lithium on oxidative stress parameters in healthy subjects. Mol Med Rep (2011) 1.05
Increased uric acid levels in drug-naïve subjects with bipolar disorder during a first manic episode. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.03
Clinical predictors of ketamine response in treatment-resistant major depression. J Clin Psychiatry (2014) 1.00
Reduced serum nerve growth factor in patients with late-life depression. Am J Geriatr Psychiatry (2013) 0.98
An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression. Int J Neuropsychopharmacol (2011) 0.97
Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants. Depress Anxiety (2013) 0.95
Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatr Dis Treat (2013) 0.95
Does gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder? Neurobiol Dis (2010) 0.94
D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression. Psychopharmacology (Berl) (2014) 0.93
Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study. Neurosci Lett (2011) 0.93
Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot study. Brain Res Bull (2011) 0.89
Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder. Expert Opin Ther Targets (2014) 0.89
Bax inhibitor 1, a modulator of calcium homeostasis, confers affective resilience. Brain Res (2011) 0.88
The immunology of bipolar disorder. Neuroimmunomodulation (2014) 0.87
Burden of maternal bipolar disorder on at-risk offspring: a controlled study on family planning and maternal care. J Affect Disord (2012) 0.87
Posture and body image in individuals with major depressive disorder: a controlled study. Rev Bras Psiquiatr (2010) 0.86
Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder. Neuropsychopharmacology (2012) 0.84
Number of manic episodes is associated with elevated DNA oxidation in bipolar I disorder. Int J Neuropsychopharmacol (2013) 0.83
Cognitive dysfunction in depression - pathophysiology and novel targets. CNS Neurol Disord Drug Targets (2014) 0.83
The impact of the CACNA1C risk allele on limbic structures and facial emotions recognition in bipolar disorder subjects and healthy controls. J Affect Disord (2012) 0.83
Association of the COMT Met¹⁵⁸ allele with trait impulsivity in healthy young adults. Mol Med Rep (2013) 0.83
Lower phosphorylated glycogen synthase kinase-3B levels in platelets of patients with schizophrenia: increment by olanzapine treatment. Eur Arch Psychiatry Clin Neurosci (2014) 0.82
Cognitive performance in depressed patients after chronic use of antidepressants. Psychopharmacology (Berl) (2006) 0.82
BDNF blood levels after electroconvulsive therapy in patients with mood disorders: a systematic review and meta-analysis. World J Biol Psychiatry (2014) 0.81
A proton magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in acute mania. Hum Psychopharmacol (2005) 0.81
Novel biomarkers for bipolar disorder. Expert Opin Med Diagn (2012) 0.81
Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes. Psychopharmacology (Berl) (2014) 0.81
Leukocyte mitochondrial DNA copy number in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.81
SHORT COMMUNICATION: Apolipoprotein E genotype and cognition in bipolar disorder. CNS Neurosci Ther (2010) 0.80
Validity and reliability of the Structured Clinical Interview for Mood Spectrum: Brazilian version (SCIMOODS-VB). Rev Bras Psiquiatr (2011) 0.79
COMT Met (158) modulates facial emotion recognition in bipolar I disorder mood episodes. J Affect Disord (2012) 0.79
Reliability and validity of a Brazilian version of the Hypomania Checklist (HCL-32) compared to the Mood Disorder Questionnaire (MDQ). Rev Bras Psiquiatr (2010) 0.79
Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial. Psychopharmacology (Berl) (2013) 0.79
The prevalence of psychopathology in offspring of bipolar women from a Brazilian tertiary center. Rev Bras Psiquiatr (2009) 0.78
Increased plasma levels of soluble TNF receptors 1 and 2 in bipolar depression and impact of lithium treatment. Hum Psychopharmacol (2015) 0.78
Gender effects of the COMT Val 158 Met genotype on verbal fluency in healthy adults. Mol Med Rep (2013) 0.78
Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder. Curr Neuropharmacol (2017) 0.78
Personality traits in bipolar disorder type I: a sib-pair analysis. Bipolar Disord (2011) 0.77
Reduced activities of phospholipases A2 in platelets of drug-naïve bipolar disorder patients. Bipolar Disord (2014) 0.77
Facial emotion recognition and its correlation with executive functions in bipolar I patients and healthy controls. J Affect Disord (2013) 0.77
[Neuropatological and neurochemical abnormalities in bipolar disorder]. Rev Bras Psiquiatr (2004) 0.77
The ARIQUELI study: potentiation of quetiapine in bipolar I nonresponders with lithium versus aripiprazole. Trials (2013) 0.77
Current pharmacological approaches and perspectives in the treatment of geriatric mood disorders. Curr Opin Psychiatry (2011) 0.76
Does BDNF genotype influence creative output in bipolar I manic patients? J Affect Disord (2012) 0.76
The impact of limbic system morphology on facial emotion recognition in bipolar I disorder and healthy controls. Neuropsychiatr Dis Treat (2013) 0.76
Synaptic plasticity in the pathophysiology and treatment of bipolar disorder. Curr Top Behav Neurosci (2011) 0.76
BDNF blood levels after non-invasive brain stimulation interventions in major depressive disorder: a systematic review and meta-analysis. World J Biol Psychiatry (2014) 0.76
Purinergic system in the treatment of bipolar disorder: uric acid levels as a screening test in mania. J Clin Psychopharmacol (2012) 0.76
A Double-Blind, Placebo-Controlled, Pilot Study of Riluzole Monotherapy for Acute Bipolar Depression. J Clin Psychopharmacol (2017) 0.75
Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in mania. J Psychiatr Res (2012) 0.75
Plasma cortisol in first episode drug-naïve mania: differential levels in euphoric versus irritable mood. J Affect Disord (2012) 0.75
Emerging Novel Treatments for Severe Mood Disorders Involving Cellular Plasticity Cascades. Curr Psychos Ther Rep (2006) 0.75
Depression and dementia of cerebrovascular origin. Rev Hosp Clin Fac Med Sao Paulo (2002) 0.75
Electroconvulsive therapy in treatment-resistant mania: case reports. Rev Hosp Clin Fac Med Sao Paulo (2002) 0.75
Psychodramatic psychotherapy combined with pharmacotherapy in major depressive disorder: an open and naturalistic study. Rev Bras Psiquiatr (2006) 0.75
Interictal psychosis: a case report and review. Rev Bras Psiquiatr (2010) 0.75
Treatment-resistant depression increases health costs and resource utilization. Rev Bras Psiquiatr (2012) 0.75
Molecular genetic case-control women investigation from the first Brazilian high-risk study on functional psychosis. Rev Bras Psiquiatr (2008) 0.75
A sib-pair analysis of impulsivity in bipolar disorder type I. Compr Psychiatry (2013) 0.75